Lactobacillus acidophilus UALa01 and Reduced Abdominal Pain

• A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.

  • 2020-05
  • RCT · n = 80
  • Digestive and Liver Disease 52(5)
  • • S. Sadrin
    • S. Sennoune
    • B. Gout
    • S. Marque
    • J. Moreau
    • Karim Zinoune
    • J. Grillasca
    • O. Pons
    • J. Maixent

  • PubMed: 31952938
  • DOI: 10.1016/j.dld.2019.12.009

  13 Insights on

  • Reduced Abdominal Pain

  • High evidence
  • Clinical

  Abdominal pain score was significantly improved in both groups at weeks 4 and 8 (P < 0.0001), but no significant differences were found between groups at week 8 (19.0 ± 2.5 vs 25.1 ± 2.6, respectively; LS Means differences = 6.0 ± 3.2; P = 0.06).

  Effect

  Neutral

  Effect size

  Small

  Significant

  No